An evaluation of persisting cognitive effects after withdrawal from long-term benzodiazepine use
- PMID: 15892904
- DOI: 10.1017/S1355617705050332
An evaluation of persisting cognitive effects after withdrawal from long-term benzodiazepine use
Abstract
Twenty participants with self-reported long-term benzodiazepine use (mean 108 months) who had previously withdrawn from medication (mean 42 months) were administered a battery of neuropsychological tests. Each long-term user was case matched for age, sex, and education to two control participants who reported never taking benzodiazepines (those with and those without anxiety). The results indicated that long-term benzodiazepine use may lead to impairments in the areas of verbal memory, motor control/performance, and nonverbal memory but not visuospatial skills and attention/concentration. The length of abstinence (> 6 months) indicates that these impairments persist well beyond cessation of benzodiazepine use. However, observed impairments in the area of nonverbal memory were not solely attributable to benzodiazepine use and may be influenced by the elevated anxiety levels present in both the case and the anxious control group.
Similar articles
-
Persistence of cognitive effects after withdrawal from long-term benzodiazepine use: a meta-analysis.Arch Clin Neuropsychol. 2004 Apr;19(3):437-54. doi: 10.1016/S0887-6177(03)00096-9. Arch Clin Neuropsychol. 2004. PMID: 15033227
-
The effects of benzodiazepines on cognition.J Clin Psychiatry. 2005;66 Suppl 2:9-13. J Clin Psychiatry. 2005. PMID: 15762814 Review.
-
Memory dysfunction in panic disorder: an investigation of the role of chronic benzodiazepine use.Depress Anxiety. 2011 Nov;28(11):999-1007. doi: 10.1002/da.20891. Epub 2011 Nov 7. Depress Anxiety. 2011. PMID: 22065537
-
Neuropsychological profile of cognitively impaired patients with schizophrenia.Compr Psychiatry. 2006 Mar-Apr;47(2):136-43. doi: 10.1016/j.comppsych.2005.05.002. Compr Psychiatry. 2006. PMID: 16490572
-
Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective.J Psychopharmacol. 2006 Mar;20(2):211-25. doi: 10.1177/0269881106059486. J Psychopharmacol. 2006. PMID: 16510479 Review.
Cited by
-
Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders.BMC Psychiatry. 2014;14 Suppl 1(Suppl 1):S1. doi: 10.1186/1471-244X-14-S1-S1. Epub 2014 Jul 2. BMC Psychiatry. 2014. PMID: 25081580 Free PMC article. Review.
-
Melatonin for sedative withdrawal in older patients with primary insomnia: a randomized double-blind placebo-controlled trial.Br J Clin Pharmacol. 2014 Jun;77(6):975-85. doi: 10.1111/bcp.12294. Br J Clin Pharmacol. 2014. PMID: 24286360 Free PMC article. Clinical Trial.
-
Change in healthcare utilization and costs following initiation of benzodiazepine therapy for long-term treatment of generalized anxiety disorder: a retrospective cohort study.BMC Psychiatry. 2012 Oct 23;12:177. doi: 10.1186/1471-244X-12-177. BMC Psychiatry. 2012. PMID: 23088742 Free PMC article.
-
Chronic use of diazepam in primary healthcare centers: user profile and usage pattern.Sao Paulo Med J. 2007 Sep 6;125(5):270-4. doi: 10.1590/s1516-31802007000500004. Sao Paulo Med J. 2007. PMID: 18094893 Free PMC article.
-
Benzodiazepines: good or bad medicine?Can Fam Physician. 2010 Nov;56(11):1097, 1099. Can Fam Physician. 2010. PMID: 21075982 Free PMC article. No abstract available.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources